|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 8/07/17 Evolent Health, Inc. 10-Q 6/30/17 80:9.7M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 908K
2: EX-10.1 Material Contract HTML 45K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
6: EX-32.2 Certification -- §906 - SOA'02 HTML 24K
13: R1 Document and Entity Information HTML 46K
14: R2 Consolidated Balance Sheets (Unaudited) HTML 117K
15: R3 Consolidated Balance Sheets (Unaudited) HTML 46K
(Parenthetical)
16: R4 Consolidated Statements of Operations (Unaudited) HTML 108K
17: R5 Consolidated Statements of Cash Flows (Unaudited) HTML 123K
18: R6 Consolidated Statements of Changes in HTML 95K
Shareholders? Equity (Deficit) (Unaudited)
19: R7 Organization HTML 29K
20: R8 Basis of Presentation, Summary of Significant HTML 71K
Accounting Policies and Change in Accounting
Principle
21: R9 Recently Issued Accounting Standards HTML 46K
22: R10 Transactions HTML 275K
23: R11 Investments HTML 69K
24: R12 Property and Equipment, Net HTML 45K
25: R13 Goodwill and Intangible Assets, Net HTML 105K
26: R14 Long-term Debt HTML 47K
27: R15 Commitments and Contingencies HTML 99K
28: R16 Earnings (Loss) Per Common Share HTML 78K
29: R17 Stock-based Compensation HTML 77K
30: R18 Income Taxes HTML 32K
31: R19 Investments In and Advances to Affiliates HTML 29K
32: R20 Non-controlling Interests HTML 57K
33: R21 Fair Value Measurement HTML 111K
34: R22 Related Parties HTML 27K
35: R23 Basis of Presentation, Summary of Significant HTML 78K
Accounting Policies and Change in Accounting
Principle (Policies)
36: R24 Basis of Presentation, Summary of Significant HTML 57K
Accounting Policies and Change in Accounting
Principle (Tables)
37: R25 Transactions (Tables) HTML 205K
38: R26 Investments (Tables) HTML 71K
39: R27 Property and Equipment, Net (Tables) HTML 40K
40: R28 Goodwill and Intangible Assets, Net (Tables) HTML 90K
41: R29 Long-term Debt (Tables) HTML 36K
42: R30 Commitments and Contingencies (Tables) HTML 73K
43: R31 Earnings (Loss) Per Common Share (Tables) HTML 80K
44: R32 Stock-based Compensation (Tables) HTML 75K
45: R33 Non-controlling Interests (Tables) HTML 47K
46: R34 Fair Value Measurement (Tables) HTML 141K
47: R35 Organization (Details) HTML 39K
48: R36 Basis of Presentation, Summary of Significant HTML 73K
Accounting Policies and Change in Accounting
Principle (Details)
49: R37 Transactions - Aldera (Details) HTML 152K
50: R38 Transactions - Valence Health (Details) HTML 253K
51: R39 Transactions - Passport (Details) HTML 68K
52: R40 Transactions - Pro Forma Information (Details) HTML 42K
53: R41 Transactions - Secondary Offerings (Details) HTML 65K
54: R42 Transactions - Accordion Health, Inc. (Details) HTML 37K
55: R43 Transactions - Vestica (Details) HTML 36K
56: R44 Investments - Investment Summary (Details) HTML 39K
57: R45 Investments - Contractual Maturity (Details) HTML 27K
58: R46 Investments - Unrealized Losses (Details) HTML 32K
59: R47 Property and Equipment, Net (Details) HTML 50K
60: R48 Goodwill and Intangible Assets, Net (Details) HTML 74K
61: R49 Goodwill and Intangible Assets, Net - Goodwill HTML 35K
(Details)
62: R50 Long-term Debt (Details) HTML 60K
63: R51 Long-term Debt - Convertible Senior Notes Carrying HTML 37K
Value and Interest Expense (Details)
64: R52 Commitments and Contingencies - Additional HTML 73K
Information (Details)
65: R53 Commitments and Contingencies - Lease Abandonment HTML 31K
Liability (Details)
66: R54 Commitments and Contingencies - Concentration Risk HTML 52K
(Details)
67: R55 Earnings (Loss) Per Common Share - Computation of HTML 53K
Earnings per Share (Details)
68: R56 Earnings (Loss) Per Common Share - Antidilutive HTML 36K
Securities (Details)
69: R57 Stock-based Compensation - Compensation Expense HTML 41K
(Details)
70: R58 Stock-based Compensation - Awards Granted HTML 31K
(Details)
71: R59 Income Taxes (Details) HTML 37K
72: R60 Investments In and Advances to Affiliates HTML 41K
(Details)
73: R61 Non-controlling Interests (Details) HTML 95K
74: R62 Fair Value Measurement - Assets and Liabilities on HTML 44K
Recurring Basis (Details)
75: R63 Fair Value Measurement - Changes in Contingent HTML 31K
Consideration (Details)
76: R64 Fair Value Measurement - Valuation Techniques and HTML 47K
Significant Unobservable Inputs (Details)
77: R65 Related Parties (Details) HTML 25K
79: XML IDEA XML File -- Filing Summary XML 141K
78: EXCEL IDEA Workbook of Financial Reports XLSX 100K
7: EX-101.INS XBRL Instance -- evh-20170630 XML 2.94M
9: EX-101.CAL XBRL Calculations -- evh-20170630_cal XML 207K
10: EX-101.DEF XBRL Definitions -- evh-20170630_def XML 921K
11: EX-101.LAB XBRL Labels -- evh-20170630_lab XML 1.54M
12: EX-101.PRE XBRL Presentations -- evh-20170630_pre XML 1.11M
8: EX-101.SCH XBRL Schema -- evh-20170630 XSD 156K
80: ZIP XBRL Zipped Folder -- 0001628908-17-000044-xbrl Zip 263K
| Exhibit |
1. | The
Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2017 (the “Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: | /s/ Frank Williams | ||
Name: Frank Williams | |||
Title: Chief Executive Officer | |||
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/7/17 | 424B2, 8-K, S-3ASR | ||
| For Period end: | 6/30/17 | 4 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/23/24 Evolent Health, Inc. 10-K 12/31/23 144:17M 2/24/23 Evolent Health, Inc. 10-K 12/31/22 148:19M 2/24/22 Evolent Health, Inc. 10-K 12/31/21 154:19M 2/26/21 Evolent Health, Inc. 10-K 12/31/20 152:19M |